FDA Inspection 947348 — Molecular Imaging Program At Stanford

Molecular Imaging Program At Stanford — FEI 3005712028

The FDA completed an inspection of Molecular Imaging Program At Stanford on Nov 3, 2015 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.